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IS THE RELATIONSHIP BETWEEN FAT MASS AND HAND
OSTEOARTHRITIS CONFOUNDED BY AGE?
F. Duboeuf, E. Sornay-Rendu, R. Chapurlat. INSERM UMR 1033, Lyon,
France
Purpose: The systemic effects of obesity are probably dependent on the
amount and distribution of adipose tissue. Most studies on osteo-
arthritis (OA) used the body mass index (BMI) as a marker for obesity,
without consideration of its distribution.
The purpose of this study was to elucidate the relationship between
hand OA and abdominal adipose tissue using a new whole body soft-Table 1. Characteristics of the population according to the severity of hand OA.
Number of osteoarthritic joints Group 0 0 Group 1 1 to 2 Group 2 3 to 7 Group 3 8 to 20 p (Anova)
n 432 99 99 100
Age (Years) 58.7 ± 10.8 66.5 ± 9.7 67.2 ± 8.5 70.4 ± 9.6 0.00
Weight (kg) 62.4 ± 10.6 61.2 ± 9.4 61.6 ± 10.5 62.1 ± 10.3 0.69
Height (cm) 159.8 ± 6.4 158.7 ± 5.6 158.2 ± 5.4 157.6 ± 5.6 0.001
Body Mass index (BMI kg/m2) 24.4 ± 4.0 24.5 ± 3.9 24.6 ± 3.9 24.9 ± 3.9 0.67
Index VFAT (g/cm2) 1.51 ± 0.93 1.67 ± 0.99 1.61 ± 0.89 1.83 ± 0.99 0.01
Index SFAT (g/cm2) 5.38 ± 2.17 5.49 ± 2.26 5.53 ± 2.19 5.87 ±2.19 0.25ware evaluating separately visceral and subcutaneous abdominal fat,
which may have different metabolic effects on joints.
Methods: Subjects : We studied a sample of 730 women (age 62.5 ±11.3
years, including 564 postmenopausal (age 66.7 ± 8.4 years), from the
OFELY cohort with available hand OA clinical evaluation.
Heberden’s nodes of the distal interphalangeal joints, Bouchard’s nodes
of the proximal interphalangeal joints, and swelling of the ﬁrst carpo-
metacarpal joints were evaluated on each hand of the subjects by a
trained rheumatologist.
OA clinical classiﬁcation according to the American College of Rheu-
matology speciﬁcation was also applied. Whole body DXA (Hologic®,
QDR4500A V 8.26) exams were analyzed using the APEX version 13.4.2
to get visceral fat mass (VFAT) and subcutaneous fat mass (SFAT) in an
abdominal region of interest at the level of the fourth lumbar
vertebrae.
Results: VFAT and SFAT were strongly associated (r¼0.87, p<.001). VFAT
and SFAT were positively correlated with age, BMI, weight and height
(VFAT : r¼0.31, p<0.001; r¼0.81, p<0.001; r¼0.73, p<0.001; r¼-0.12,
p<0.001 respectively); (SFAT : r¼0.16, p<0.001; r¼0.88, p<0.001;
r¼0.80, p<0.001; r¼ -0.12, p<0.001 respectively) The number of joints
with hand OA was weakly correlated with VFAT but not with SFAT
(r¼0.11, p¼0.003; r¼0.04, p¼0.24, respectively).
To assess the association between fat and the severity of hand OA, we
have divided the sample into four groups (group 0 : 432 subjects
without hand OA ; group 1: 99 subjects with 1-2 OA joints; group 2: 99
subjects with3-7 OA joints and group 3 : 100 subjects with 8-20 OA
joints). Height was signiﬁcantly different between groups (See Table 1).1063-4584/$ e see front matterBased on the histogram of the number of OA joints versus VFAT,
threshold hand OA status was deﬁned as more than 8 AO joints (Table 1;
Group 3). Multivariate analysis was performed using logistic regression.
For height correction, index-VFAT-(VFAT/Height2) and index-SFAT
(SFAT/Height2) were deﬁned and used in the model.
After adjustment for age, neither index-VFAT nor index-SFAT were
associated with hand OA both in the whole and postmenopausal pop-
ulations. Similar results were found when ACR hand OA classiﬁcation
was used.
Conclusions: The relationship between abdominal fat (visceral or
subcutaneous) and hand OA seems to be confounded by increasing
age.Biomarkers
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INFRARED-BASED DETECTION OF AN OSTEOARTHRITIS BIOMARKER
SIGNATURE IN THE SERUM OF RABBITS WITH INDUCED
OSTEOARTHRITIS
C.B. Riley y,z, S. Laverty x, S. Hou z, R.A. Shaw x. yMassey Univ., Palmerston
North, New Zealand; zUniv. of Prince Edward Island, Charlottetown, PE,
Canada; xUniv. de Montreal, Saint-Hyacinthe, QC, Canada; kNatl. Res.
Council of Canada, Winnipeg, MB, Canada
Purpose: Earlier and economic screening for the diagnosis and mon-
itoring of osteoarthritis (OA) is required to allow timely intervention
with preventive therapy to arrest or reverse structural degradation, and
to minimize the disabling effects of OA. Biomarkers have gained
widespread acceptance as tools for the characterization of OA and
clinical trial responses, but progress in their use as screening tools in
susceptible populations is limited. Previously we reported infrared (IR)
spectroscopic algorithms capable of diagnosing OAwith small amounts
( mLs) of joint ﬂuid in animals with naturally occurring disease with a
minimal cost per test. Based on this work, we hypothesize that inex-
pensive and accurate IR spectroscopic methods, combined with
appropriate algorithms, can be used to diagnose and monitor the pro-
gression of OA using serum, a more easily obtainable bioﬂuid.
Methods: 32 skeletally mature female New Zealand rabbits with a
mean weight of 4.7 kg were studied. The rabbits were fed and housed
in compliance with Canadian Council on Animal Care guidelines.
Animals were randomly divided into 2 groups: 16 for induction of OA
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thesia, and 16 controls.Pre-operative radiographs of the femorotibial
joints were performed to exclude animals with pathology. Rabbits
were anesthetized and ACLT performed through a medial parapatellar
incision. Serumwas collected at -14 (baseline), 7, 14, 28, 42, 56, 70 and
84 days post-ACLT and aliquots were frozen at -20C until analysis.
Eight mL of the diluted thawed serum (1:1 in 4% KSCN) was placed in 5
mm diameter circular wells on an adhesive-masked silicon micro-
plate. Once dry, the microplate was mounted in a Fourier-transform
infrared spectrometer (FTIR; Tensor 37, Bruker Optics, Milton, Canada)
for the acquisition of IR absorbance spectra (400-4000 cm-1). For
each acquisition, 512 interferograms were signal averaged and Fourier
transformed to generate a spectrum with a nominal resolution of 4
cm-1. Spectra generated from each sample were averaged, differ-
entiated and smoothed to resolve and enhance weak spectral features
and to remove variation in baselines, using spectral manipulation
software. Following preprocessing, partial least squares discriminant
analysis (PLS-DA) was applied to the IR spectra at each time point
using script written in MatLab®. Variables contributing to the sepa-
ration of groups were selected using t-statistic, PLS weights and
regression coefﬁcients. Monte-Carlo methods were employed to
determine the empirical signiﬁcance of variables for separating
groups, by randomly permuting the class membership 5000 times to
obtain null distributions, and comparing the observed statistic for
each variable with the null distribution. The PLS-DA optimal model
was considered valid for Q2 (one minus the ratio of the prediction
error sum of squares over the total sum of squares of the response
vector) values signiﬁcant at P < 0.05.
Results: Infrared spectroscopic spectra combined with a PLS-DA clas-
siﬁcation strategy, generated IR-based serum biomarker proﬁles that
successfully discriminated between ACLT and control rabbits. Differ-
ences were signiﬁcant at 7, 14, 28, 42, 56, 70 and 84 days post-ACLT. The
distribution of t-statistic, PLS weights and regression coefﬁcients varied
signiﬁcantly between time points, indicating the potential of the
approach for monitoring the progression of osteoarthritis.
Conclusions: “Multiplexed” approaches have emerged in recent years
for the identiﬁcation and veriﬁcation of novel OA biomarkers,
employing genomic, proteomic and metabolomic tools. Although IR
spectroscopy has been used for rheumatoid arthritis, this study is the
ﬁrst to employ IR spectroscopy and PLS-DA to screen serum for a bio-
marker signature reﬂective of OA, encompassing both known and
unknown markers of disease. The ideal biomarker approach should be
rapidly and simply performed, yield accurate results, identify pro-
gression,differentiate between early and late stages of disease, and use
small volumes of easily accessible body ﬂuid. The method described
here achieves many of these ideals with fewer technical and less
expensive infrastructure requirements than others. Nevertheless access
to a larger number of well characterized biological samples is required
for more extensive validation.
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BASELINE FIBULIN3 CONCENTRATIONS ARE ASSOCIATED WITH
INCIDENCE OF CLINICAL KNEE OA AFTER 30 MONTHS IN
OVERWEIGHT AND OBESE WOMEN
J. Runhaar y,z, C. Sanchez x,k, Y. Henrotin x,x, S.M. Bierma-Zeinstra y,z.
y Erasmus MC Univ. Med. Ctr. Rotterdam, Rotterdam, Netherlands;
zD-BOARD Consortium (EU-FP7; 305815), Rotterdam, Netherlands;
xUniv. of Liege, Liege, Belgium; kD-BOARD Consortium (EU-FP7;
305815), Liege, Belgium
Purpose: Fibuline3 is highly expressed in osteoarthritic cartilage and
inhibits angiogenesis and chondrocyte differentiation. It has been
demonstrated to interact with the tissue inhibitor of metalloprotease
(TIMP)-3, which is a matrix bound inhibitor of matrix metal-
loproteinases (MMPs) and stimulates the expression of TIMP-1 and
TIMP-3, but inhibits the expression and activities of MMP-2, MMP-3,
and MMP-9. In the present study, the association between three Fibu-
lin3 peptides identiﬁed by proteomics and the incidence of radio-
graphic and clinical knee osteoarthritis (OA) in middle-aged overweight
and obese women, free of radiographic and symptomatic knee OA at
baseline was tested.
Methods: Women between 50 and 60 years, with a BMI  27 kg/m2,
free of knee OA were recruited through their general practitioner. At
baseline, physical examination including serum collection was
performed and radiographs and questionnaires on knee complaintswere obtained. Using binary logistic regression, the association
between baseline concentration of Fibulin(Fib)3-1, Fib3-2 and Fib3-3
and incidence of clinical and radiographic knee OA after 30
months of follow-up was tested, adjusting for age, BMI, and other
potential covariates that were identiﬁed in multivariable regression
analyses.
Results: Baseline serum samples and follow-up measurements were
available for 242 women. Mean agewas 55.9 ± 3.2 years, mean BMI was
31.6 ± 3.6 kg/m2 and 70%was postmenopausal. All subjects were free of
clinical and radiographic knee OA at baseline, but 24% had a unilateral
K&L score of 1 and 33% bilaterally. Mild symptoms were present in 24%
and 17% of the subjects, uni- and bilaterally respectively. Baseline
concentrations of all Fib3 fragments were log-transformed for a normal
distribution and z-transformed for uniformity reasons. Correlation
coefﬁcients for the baseline concentrations of the three Fib3 fragments
ranged from 0.13 to 0.58. Neither of the concentrations of the three Fib3
fragments were associated with incidence of medial or lateral joint
space narrowing  1.0 mm. or incidence of K&L grade 2. All three Fib3
fragments were associated with incidence of the clinical and radio-
graphic ACR-criteria and Fib3-1 and Fib3-3 also with chronic pain at
follow-up (see ﬁgure). When adjusted for the other Fib3 peptide con-
centrations, only Fib3-1 was signiﬁcantly associated to the incidence of
the ACR criteria (OR 2.5 [1.0-6.2]) and chronic pain at follow-up (OR 2.6
[1.1-5.9]).
Conclusions: Baseline Fibulin3 concentrations are associated to the
incidence of clinical knee OA amongmiddle-aged overweight and obese
women. Therewith, they meet the criteria of a prognostic biomarker
according to the BIPED biomarker classiﬁcation for OA. Further vali-
dation of the Fibulin3 fragments seems warranted in order to better
distinguish subgroups of individuals at increased risk for knee OA
development.
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DETECTION OF CTXII IN THE RAT KNEE VIA MAGNETIC BIOMARKER
CAPTURE
E.G. Yarmola, D.P. Arnold, J.P. Dobson, K.D. Allen. Univ. of Florida,
Gainesville, FL, USA
Purpose: Osteoarthritis (OA) biomarker development often begins
with rodent models; however, methods to recover OA biomarkers from
rodent joints are not ideal. In large human joints, synovial ﬂuid can be
aspirated for biomarker analysis, but synovial ﬂuid aspiration from a
rat knee is limited by complex joint geometries and small ﬂuid vol-
umes. Instead, saline is often used to lavage synovial ﬂuid from the
joint, but lavage has limitations, including: 1) Lavage ﬂuids dilute
biomarker concentrations; 2) Mixing saline with highly viscous
synovial ﬂuid is not trivial and verifying ﬂuids are well-mixed prior to
removal from the rodent knee is practically impossible; and 3) Esti-
mation of joint-level biomarker concentrations is susceptible to joint
effusion. To address these limitations, our group has developed a
magnetic nanoparticle-based technology to collect OA biomarkers
from synovial ﬂuid in situ, termed magnetic capture. Using polymeric
particles that contain superparamagnetic iron oxide nanoparticles
(SPIONs) and are surface-functionalized with a targeting molecule, OA
biomarkers can be magnetically collected from a rodent knee without
